Skip to main content
Equibles

MetLife Investment Management, LLC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1529735 Whippany, NJ
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$226,602
+$30,307 QoQ
Shares Held
15,542
0.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 122 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. ENTA ranks #184 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in ENTA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $226,602 15,542
2026-03-31 $196,295 15,542
2025-12-31 $227,214 14,408
2025-09-30 $78,511 6,559
2025-06-30 $98,393 13,015
2025-03-31 $72,196 13,079
2024-09-30 $118,663 11,454
2024-06-30 $148,558 11,454
2024-03-31 $180,536 10,340
2023-12-31 $97,299 10,340
2023-09-30 $115,497 10,340
2023-06-30 $221,276 10,340
2023-03-31 $418,149 10,340
2022-12-31 $481,016 10,340
2022-09-30 $536,335 10,340
2022-06-30 $518,031 10,959
2022-03-31 $780,061 10,959
2021-12-31 $509,999 6,820
2021-09-30 $387,444 6,820
2021-06-30 $365,018 8,294
2021-03-31 $409,060 8,294
2020-12-31 $349,177 8,294
2020-09-30 $379,699 8,294
2020-06-30 $416,441 8,294
2020-03-31 $426,560 8,294